Global Skin Microbiome Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Skin Microbiome Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Healthcare
  • Apr 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Author : Sachin Pawar

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Skin Microbiome Market

Market Size in USD Billion

CAGR :  % Diagram

Bar chart comparing the Global Skin Microbiome Market size in 2024 - 1.03 and 2032 - 2.86, highlighting the projected market growth. USD 1.03 Billion USD 2.86 Billion 2024 2032
Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 1.03 Billion
Diagram Market Size (Forecast Year)
USD 2.86 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Aurelia Skincare Ltd.
  • Gallin&eacute
  • e
  • Mother Dirt
  • Esse Skincare

Global Skin Microbiome Market Segmentation, By Type (Resident Microorganisms and Transient Bacteria), Skin Type (Dry, Moist and Oily), Diseases (Acne Vulgaris, Atopic Dermatitis, Psoriasis Vulgaris and Rosacea) - Industry Trends and Forecast to 2032

Skin Microbiome Market

Skin Microbiome Market Size

  • The global skin microbiome market was valued at USD 1.03 billion in 2024 and is expected to reach USD 2.86 billion by 2032
  • During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.68%, primarily driven by the rising consumer awareness of skin health and the increasing demand for probiotic and microbiome-friendly skincare products
  • This growth is driven by factors such as the increasing prevalence of skin disorders, advancements in microbiome research, and rising demand for personalized skincare solutions

Skin Microbiome Market Analysis

  • The skin microbiome refers to the community of microorganisms—including bacteria, fungi, viruses, and mites—that naturally live on the skin of humans and other animals. These microbes play a key role in maintaining skin health, protecting against harmful pathogens, supporting the immune system, and even influencing skin conditions such as acne, eczema, and psoriasis
  • The growth in this market is significantly driven by increasing consumer awareness about skin microbiota, rising demand for natural and probiotic skincare, and growing interest in personalized beauty and wellness solutions
  • North America stands out as one of the dominant regions for the skin microbiome market, driven by a strong presence of major skincare and pharmaceutical companies, high consumer spending on innovative skincare products, and growing demand for wellness-driven beauty solutions 
    • For instance, the U.S. market has seen a surge in microbiome-focused skincare launches, supported by dermatological research, consumer education, and the rapid growth of direct-to-consumer beauty brands embracing microbiome science
  • Globally, skin microbiome-based products are becoming a cornerstone in the evolution of skincare, emerging as a leading category within dermocosmetics and playing a transformative role in the future of skin health and personalized beauty care

Report Scope and Skin Microbiome Market Segmentation   

Attributes

Skin Microbiome Key Market Insights

Segments Covered

  • By Type: Resident Microorganisms and Transient Bacteria
  • By Skin Type: Dry, Moist, and Oily
  • By Disease: Acne Vulgaris, Atopic Dermatitis, Psoriasis Vulgaris and Rosacea

Countries Covered

North America

  • U.S.
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • U.K.
  • Netherlands
  • Switzerland
  • Belgium
  • Russia
  • Italy
  • Spain
  • Turkey
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of Asia-Pacific

Middle East and Africa

  • Saudi Arabia
  • U.A.E.
  • South Africa
  • Egypt
  • Israel
  • Rest of Middle East and Africa

South America

  • Brazil
  • Argentina
  • Rest of South America

Key Market Players

  • Aurelia London (U.K.)
  • GALLINÉE (U.K.)
  • Esse Skincare (South Africa)
  • S-BIOMEDIC (Belgium)
  • Elizabeth Arden (Switzerland)
  • YUN (Belgium)
  • TULA Life, Inc. (U.S.)
  • The Beauty Chef (Australia)
  • L’Oreal Paris (France)
  • Clinique Laboratories, llc. (U.S.)
  • La Roche-Posay (France)
  • BEBE & BELLA (U.S.)
  • ILDONG PHARMACEUTICAL CO.,LTD. (South Korea)
  • AMOREPACIFIC US, INC. (South Korea)
  • BELANO medical AG (Germany)
  • Interpharma Group (Thailand)
  • GLOWBIOTICS (U.S.)
  • Börlind GmbH (Germany)
  • BIOMILK Skincare (Israel)
  • SkinBioTherapeutics PLC (U.K.)

Market Opportunities

  • Leveraging AI and Genomic Technologies for Personalized Skincare
  • Expansion of microbiome-friendly cosmetics and therapeutics for sensitive skin and chronic conditions

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Skin Microbiome Market Trends

“Rising Focus on Personalized and Probiotic Skincare Solutions”

  • One prominent trend in the global skin microbiome market is the increasing focus on personalized and probiotic skincare solutions tailored to individual skin microbiota profiles
  • These innovative approaches aim to balance and support the skin’s natural microbiome, leading to healthier skin and improved management of conditions such as acne, rosacea, and dryness 
    • For instance, companies are leveraging skin microbiome testing to develop customized skincare regimens based on an individual's unique microbial composition, enhancing efficacy and user satisfaction
  • Probiotic and prebiotic formulations are also gaining popularity, as they help nourish beneficial skin bacteria and strengthen the skin barrier, appealing to consumers seeking natural and science-backed skincare
  • This trend is transforming the skincare industry by aligning with the growing demand for wellness-focused, science-driven, and personalized beauty products, fueling innovation and growth in the global skin microbiome market

Skin Microbiome Market Dynamics

Driver

“Increasing Skin Disorders and Demand for Natural, Microbiome-Friendly Solutions”

  • The growing prevalence of skin disorders such as acne, eczema, rosacea, and psoriasis is a major driver for the increasing demand in the skin microbiome market
  • As consumers become more aware of the role the skin microbiome plays in maintaining skin health, there is a rising shift towards products that support and restore the natural balance of skin microorganisms
  • Traditional skincare products often contain harsh chemicals that disrupt the skin barrier, leading to increased interest in probiotic, prebiotic, and microbiome-friendly formulations that are gentler and more effective for sensitive or compromised skin
  • The Advancements in dermatological and microbiome research have made it possible to create targeted, science-backed skincare solutions that cater to individual microbiome needs, further fueling market growth
  • With an increasing number of consumers experiencing chronic or environmentally-triggered skin conditions, the demand for skin microbiome-based products continues to grow as a safer and more holistic alternative to conventional treatments

For instance,

  • In June 2023, a study published in the Journal of Investigative Dermatology emphasized the link between disrupted skin microbiota and inflammatory skin conditions such as eczema and acne, suggesting microbiome-based therapies as promising interventions
  • In October 2022, the American Academy of Dermatology highlighted growing consumer interest in microbiome-supportive skincare, with dermatologists increasingly recommending microbiome-safe products for sensitive skin management 
  • As skin disorders become more prevalent and consumers prioritize long-term skin health, the demand for microbiome-focused skincare solutions is expected to accelerate, making it a key driver of growth in the global skin microbiome market

Opportunity

“Leveraging AI and Genomic Technologies for Personalized Skincare”

  • The integration of artificial intelligence (AI) and genomic technologies presents a significant opportunity in the global skin microbiome market, enabling the development of highly personalized skincare solutions based on an individual’s unique skin microbiota and genetic profile
  •  AI-powered platforms can analyze vast datasets from skin microbiome tests, environmental factors, and lifestyle inputs to generate tailored product recommendations, improving skincare efficacy and customer satisfaction
  • By combining machine learning with microbiome sequencing, brands can create adaptive skincare regimens that evolve with changes in the user's skin health, environment, or age—offering dynamic, real-time customization

For instance,

  • In August 2024, a study published in Frontiers in Microbiology highlighted how AI-driven analysis of skin microbiome samples led to the successful development of individualized skincare treatments, which significantly improved barrier function and reduced inflammation in patients with atopic dermatitis
  •  In March 2023, a U.S.-based biotech company launched an AI-enabled skin testing kit that combines microbiome data with genomics to deliver hyper-personalized skincare routines, marking a leap forward in precision skincare 
  • The integration of AI and microbiome science opens new avenues for innovation, allowing brands to offer smarter, data-backed skincare solutions. This not only enhances user experience and product effectiveness but also strengthens consumer trust and loyalty—positioning it as a major growth opportunity for the global skin microbiome market

Restraint/Challenge

“High Development Costs and Regulatory Hurdles Limiting Market Expansion”

  • The high costs associated with research, development, and testing of microbiome-based skincare products present a significant challenge for market growth, especially for smaller companies and startups
  • These formulating products that effectively support or restore the skin microbiome requires advanced biotechnological processes, clinical trials, and rigorous safety assessments, all of which contribute to increased time and financial investment
  • In addition, the evolving and often unclear regulatory landscape surrounding microbiome-focused skincare products adds further complexity, slowing product approvals and limiting market entry for new players

For instance,

  • In May 2023, according to a report published by Skin Health Alliance, the development of microbiome-based skincare involves challenges in identifying beneficial strains, ensuring product stability, and proving efficacy through scientific validation—all of which drive up production costs
  • In July 2022, the Global Cosmetic Regulatory Summit noted that while interest in microbiome skincare is growing, the absence of standardized global regulations on probiotics and live bacteria in cosmetics is creating uncertainty for manufacturers and limiting international expansion 
  • Consequently, high development costs and regulatory ambiguity can slow innovation, restrict access to new products, and create disparities in availability across different regions, ultimately restraining the full growth potential of the global skin microbiome market

Skin Microbiome Market Scope

The market is segmented on the basis of type, skin type, and disease.

Segmentation

Sub-Segmentation

By Type

  • Resident Microorganisms
  • Transient Bacteria

By Skin Type

  • Dry
  • Moist
  • Oily

By Disease

  • Acne Vulgaris
  • Atopic Dermatitis
  • Psoriasis Vulgaris
  • Rosacea

Skin Microbiome Market Regional Analysis

North America is the Dominant Region in the Skin Microbiome Market

  • North America leads the global skin microbiome market, driven by high consumer awareness, widespread adoption of probiotic and science-backed skincare, and the strong presence of major skincare and biotechnology companies
  • U.S. holds a significant share owing to growing demand for personalized skincare solutions, increased prevalence of skin conditions such as acne and eczema, and an established culture of wellness-focused beauty consumption
  • The region benefits from advanced dermatological research capabilities, rising interest in microbiome-based therapeutics, and the proliferation of direct-to-consumer brands utilizing AI and skin testing to deliver personalized product recommendations
  • In addition, robust investment in research and development, coupled with collaborations between biotech firms and cosmetic brands, continues to strengthen innovation and commercialization of microbiome-focused products in the region

Asia-Pacific is Projected to Register the Highest Growth Rate

  • Asia-Pacific is expected to experience the fastest growth in the global skin microbiome market, fueled by rising awareness of skin health, increasing disposable income, and growing demand for clean, natural, and customized skincare
  • Countries such as China, South Korea, Japan, and India are emerging as high-potential markets due to their large, youthful populations and expanding interest in skin wellness and preventative skincare solutions
  • Japan, known for its cutting-edge beauty innovations and strong regulatory support, remains a leader in microbiome-related skincare technologies. South Korea, with its influential beauty industry, is also driving adoption of microbiome-friendly products
  • In China and India, rapid urbanization, environmental stressors, and a growing middle class are contributing to higher incidences of skin conditions, encouraging demand for innovative, microbiome-supportive skincare solutions. The increasing entry of international brands and investment in R&D across the region is further propelling market expansion

Skin Microbiome Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

  • Aurelia London (U.K.)
  • GALLINÉE (U.K.)
  • Esse Skincare (South Africa)
  • S-BIOMEDIC (Belgium)
  • Elizabeth Arden (Switzerland)
  • YUN (Belgium)
  • TULA Life, Inc. (U.S.)
  • The Beauty Chef (Australia)
  • L’Oreal Paris (France)
  • Clinique Laboratories, llc. (U.S.)
  • La Roche-Posay (France)
  • BEBE & BELLA (U.S.)
  • ILDONG PHARMACEUTICAL CO.,LTD. (South Korea)
  • AMOREPACIFIC US, INC. (South Korea)
  • BELANO medical AG (Germany)
  • Interpharma Group (Thailand)
  • GLOWBIOTICS (U.S.)
  • Börlind GmbH (Germany)
  • BIOMILK Skincare (Israel)
  • SkinBioTherapeutics PLC (U.K.)

Latest Developments in Global Skin Microbiome Market

  • In February 2025, Phyla, a skincare brand backed by Ryan Reynolds, launched a breakthrough acne treatment using bacteriophages to target Cutibacterium acnes, the bacteria primarily responsible for acne. The Acne Phage Serum (USD 70) offers a natural and highly targeted method, with early users reporting notable improvements
  • In December 2024, French brand Gallinée released a microbiome-friendly Anti-Ageing Face Recovery Mask, formulated with prebiotics and probiotics to support skin barrier restoration, hydration, and radiance
  • In September 2024, Evonik introduced a new lab model that realistically simulates skin microbiota to test cosmetic ingredients. This allows brands to create scientifically validated, microbiome-supporting skincare products
  • In March 2024, POND’S launched a Microbiome Analyzer pilot in the Philippines, offering skin swab analysis with AI-driven, personalized skincare recommendations within an hour—part of its mission to deliver science-backed beauty at scale
  • In March 2024, New Zealand-based Emma Lewisham’s brand reported NZD USD13 million in sales with projections to double, driven by its commitment to sustainability and microbiome-conscious, natural skincare

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL SKIN MICROBIOME MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL SKIN MICROBIOME MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 EPIDEMIOLOGY BASED MODEL

2.2.11 VENDOR SHARE ANALYSIS

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL SKIN MICROBIOME MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 REGULATORY SCENARIO

5.2 PESTEL ANALYSIS

5.3 PORTER’S 5 FORCES

5.4 REIMBURSMENT SCENARIO

6 INDUSTRY INSIGHTS

7 REGULATORY FRAMEWORK

8 GLOBAL SKIN MICROBIOME MARKET, BY PRODUCT

9 NOTE: MARKET VALUE, VOLUME AND ASP ANALYSIS WOULD BE PROVIDED FOR ALL SEGMENTS AND SUB-SEGMENTS OF PRODUCT)

9.1 OVERVIEW

9.2 PROBIOTIC

9.2.1 LACTOCOCCUS

9.2.1.1. TOPICAL

9.2.1.1.1. SPRAY

9.2.1.1.1.1 MARKET VALUE(USD MILLION)

9.2.1.1.1.2 MARKET VOLUME(UNITS)

9.2.1.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.2. SERUM

9.2.1.1.2.1 MARKET VALUE(USD MILLION)

9.2.1.1.2.2 MARKET VOLUME(UNITS)

9.2.1.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.3. MOISTURIZER

9.2.1.1.3.1 MARKET VALUE(USD MILLION)

9.2.1.1.3.2 MARKET VOLUME(UNITS)

9.2.1.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.4. OIL

9.2.1.1.4.1 MARKET VALUE(USD MILLION)

9.2.1.1.4.2 MARKET VOLUME(UNITS)

9.2.1.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.5. CLEANSER

9.2.1.1.5.1 MARKET VALUE(USD MILLION)

9.2.1.1.5.2 MARKET VOLUME(UNITS)

9.2.1.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.6. GELS

9.2.1.1.6.1 MARKET VALUE(USD MILLION)

9.2.1.1.6.2 MARKET VOLUME(UNITS)

9.2.1.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.7. MASKS

9.2.1.1.7.1 MARKET VALUE(USD MILLION)

9.2.1.1.7.2 MARKET VOLUME(UNITS)

9.2.1.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.8. PRIMERS

9.2.1.1.8.1 MARKET VALUE(USD MILLION)

9.2.1.1.8.2 MARKET VOLUME(UNITS)

9.2.1.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.1.1.9. OTHERS

9.2.1.2. ORAL

9.2.1.3. OTHERS

9.2.2 BIFIDOBACTERIUM

9.2.2.1. TOPICAL

9.2.2.1.1. SPRAY

9.2.2.1.1.1 MARKET VALUE(USD MILLION)

9.2.2.1.1.2 MARKET VOLUME(UNITS)

9.2.2.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.2. SERUM

9.2.2.1.2.1 MARKET VALUE(USD MILLION)

9.2.2.1.2.2 MARKET VOLUME(UNITS)

9.2.2.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.3. MOISTURIZER

9.2.2.1.3.1 MARKET VALUE(USD MILLION)

9.2.2.1.3.2 MARKET VOLUME(UNITS)

9.2.2.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.4. OIL

9.2.2.1.4.1 MARKET VALUE(USD MILLION)

9.2.2.1.4.2 MARKET VOLUME(UNITS)

9.2.2.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.5. CLEANSER

9.2.2.1.5.1 MARKET VALUE(USD MILLION)

9.2.2.1.5.2 MARKET VOLUME(UNITS)

9.2.2.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.6. GELS

9.2.2.1.6.1 MARKET VALUE(USD MILLION)

9.2.2.1.6.2 MARKET VOLUME(UNITS)

9.2.2.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.7. MASKS

9.2.2.1.7.1 MARKET VALUE(USD MILLION)

9.2.2.1.7.2 MARKET VOLUME(UNITS)

9.2.2.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.8. PRIMERS

9.2.2.1.8.1 MARKET VALUE(USD MILLION)

9.2.2.1.8.2 MARKET VOLUME(UNITS)

9.2.2.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.2.1.9. OTHERS

9.2.2.2. ORAL

9.2.2.3. OTHERS

9.2.3 STREPTOCOCCUS THERMOPHILUS

9.2.3.1. TOPICAL

9.2.3.1.1. SPRAY

9.2.3.1.1.1 MARKET VALUE(USD MILLION)

9.2.3.1.1.2 MARKET VOLUME(UNITS)

9.2.3.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.2. SERUM

9.2.3.1.2.1 MARKET VALUE(USD MILLION)

9.2.3.1.2.2 MARKET VOLUME(UNITS)

9.2.3.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.3. MOISTURIZER

9.2.3.1.3.1 MARKET VALUE(USD MILLION)

9.2.3.1.3.2 MARKET VOLUME(UNITS)

9.2.3.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.4. OIL

9.2.3.1.4.1 MARKET VALUE(USD MILLION)

9.2.3.1.4.2 MARKET VOLUME(UNITS)

9.2.3.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.5. CLEANSER

9.2.3.1.5.1 MARKET VALUE(USD MILLION)

9.2.3.1.5.2 MARKET VOLUME(UNITS)

9.2.3.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.6. GELS

9.2.3.1.6.1 MARKET VALUE(USD MILLION)

9.2.3.1.6.2 MARKET VOLUME(UNITS)

9.2.3.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.7. MASKS

9.2.3.1.7.1 MARKET VALUE(USD MILLION)

9.2.3.1.7.2 MARKET VOLUME(UNITS)

9.2.3.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.8. PRIMERS

9.2.3.1.8.1 MARKET VALUE(USD MILLION)

9.2.3.1.8.2 MARKET VOLUME(UNITS)

9.2.3.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.3.1.9. OTHERS

9.2.3.2. ORAL

9.2.3.3. OTHERS

9.2.4 SACCHAROMYCES

9.2.4.1. TOPICAL

9.2.4.1.1. SPRAY

9.2.4.1.1.1 MARKET VALUE(USD MILLION)

9.2.4.1.1.2 MARKET VOLUME(UNITS)

9.2.4.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.2. SERUM

9.2.4.1.2.1 MARKET VALUE(USD MILLION)

9.2.4.1.2.2 MARKET VOLUME(UNITS)

9.2.4.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.3. MOISTURIZER

9.2.4.1.3.1 MARKET VALUE(USD MILLION)

9.2.4.1.3.2 MARKET VOLUME(UNITS)

9.2.4.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.4. OIL

9.2.4.1.4.1 MARKET VALUE(USD MILLION)

9.2.4.1.4.2 MARKET VOLUME(UNITS)

9.2.4.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.5. CLEANSER

9.2.4.1.5.1 MARKET VALUE(USD MILLION)

9.2.4.1.5.2 MARKET VOLUME(UNITS)

9.2.4.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.6. GELS

9.2.4.1.6.1 MARKET VALUE(USD MILLION)

9.2.4.1.6.2 MARKET VOLUME(UNITS)

9.2.4.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.7. MASKS

9.2.4.1.7.1 MARKET VALUE(USD MILLION)

9.2.4.1.7.2 MARKET VOLUME(UNITS)

9.2.4.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.8. PRIMERS

9.2.4.1.8.1 MARKET VALUE(USD MILLION)

9.2.4.1.8.2 MARKET VOLUME(UNITS)

9.2.4.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.4.1.9. OTHERS

9.2.4.2. ORAL

9.2.4.3. OTHERS

9.2.5 LACTOBACILLUS

9.2.5.1. TOPICAL

9.2.5.1.1. SPRAY

9.2.5.1.1.1 MARKET VALUE(USD MILLION)

9.2.5.1.1.2 MARKET VOLUME(UNITS)

9.2.5.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.2. SERUM

9.2.5.1.2.1 MARKET VALUE(USD MILLION)

9.2.5.1.2.2 MARKET VOLUME(UNITS)

9.2.5.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.3. MOISTURIZER

9.2.5.1.3.1 MARKET VALUE(USD MILLION)

9.2.5.1.3.2 MARKET VOLUME(UNITS)

9.2.5.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.4. OIL

9.2.5.1.4.1 MARKET VALUE(USD MILLION)

9.2.5.1.4.2 MARKET VOLUME(UNITS)

9.2.5.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.5. CLEANSER

9.2.5.1.5.1 MARKET VALUE(USD MILLION)

9.2.5.1.5.2 MARKET VOLUME(UNITS)

9.2.5.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.6. GELS

9.2.5.1.6.1 MARKET VALUE(USD MILLION)

9.2.5.1.6.2 MARKET VOLUME(UNITS)

9.2.5.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.7. MASKS

9.2.5.1.7.1 MARKET VALUE(USD MILLION)

9.2.5.1.7.2 MARKET VOLUME(UNITS)

9.2.5.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.8. PRIMERS

9.2.5.1.8.1 MARKET VALUE(USD MILLION)

9.2.5.1.8.2 MARKET VOLUME(UNITS)

9.2.5.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.5.1.9. OTHERS

9.2.5.2. ORAL

9.2.5.3. OTHERS

9.2.6 LEUCONOSTOC

9.2.6.1. TOPICAL

9.2.6.1.1. SPRAY

9.2.6.1.1.1 MARKET VALUE(USD MILLION)

9.2.6.1.1.2 MARKET VOLUME(UNITS)

9.2.6.1.1.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.2. SERUM

9.2.6.1.2.1 MARKET VALUE(USD MILLION)

9.2.6.1.2.2 MARKET VOLUME(UNITS)

9.2.6.1.2.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.3. MOISTURIZER

9.2.6.1.3.1 MARKET VALUE(USD MILLION)

9.2.6.1.3.2 MARKET VOLUME(UNITS)

9.2.6.1.3.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.4. OIL

9.2.6.1.4.1 MARKET VALUE(USD MILLION)

9.2.6.1.4.2 MARKET VOLUME(UNITS)

9.2.6.1.4.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.5. CLEANSER

9.2.6.1.5.1 MARKET VALUE(USD MILLION)

9.2.6.1.5.2 MARKET VOLUME(UNITS)

9.2.6.1.5.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.6. GELS

9.2.6.1.6.1 MARKET VALUE(USD MILLION)

9.2.6.1.6.2 MARKET VOLUME(UNITS)

9.2.6.1.6.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.7. MASKS

9.2.6.1.7.1 MARKET VALUE(USD MILLION)

9.2.6.1.7.2 MARKET VOLUME(UNITS)

9.2.6.1.7.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.8. PRIMERS

9.2.6.1.8.1 MARKET VALUE(USD MILLION)

9.2.6.1.8.2 MARKET VOLUME(UNITS)

9.2.6.1.8.3 AVERAGE SELLING PRICE(ASP)

9.2.6.1.9. OTHERS

9.2.6.2. ORAL

9.2.6.3. OTHERS

9.3 PREBIOTIC

9.3.1 PLANT BASED

9.3.2 SYNTHESIZED

9.4 OTHERS

10 GLOBAL SKIN MICROBIOME MARKET, BY TYPES

10.1 OVERVIEW

10.2 RESIDENT MICROORGANISMS

10.3 TRANSIENT BACTERIA

11 GLOBAL SKIN MICROBIOME MARKET, BY DISEASE

11.1 OVERVIEW

11.2 ATOPIC DERMATITIS

11.3 ACNE VULGARIS

11.4 ROSACEA

11.5 PSORIASIS VULGARIS

11.6 ATOPIC DERMATITIS

11.7 PEMPHIGUS

11.8 ALOPECIA AREATA

11.9 EPIDERMOLYSIS BULLOSA

11.1 SCLERODERMA

11.11 ICHTHYOSIS

11.12 VITILIGO

11.13 OTHERS

12 GLOBAL SKIN MICROBIOME MARKET, BY ROUTE OF ADMINISTRATION

12.1 OVERVIEW

12.2 TOPICAL

12.3 ORAL

13 GLOBAL SKIN MICROBIOME MARKET, BY SKIN TYPE

13.1 OVERVIEW

13.2 MOIST SKIN

13.2.1 TOPICAL

13.2.2 ORAL

13.3 DRY SKIN

13.3.1 TOPICAL

13.3.2 ORAL

13.4 OILY SKIN

13.4.1 TOPICAL

13.4.2 ORAL

13.5 OTHER

14 GLOBAL SKIN MICROBIOME MARKET, BY POPULATION TYPE

14.1 OVERVIEW

14.2 MEN

14.3 WOMEN

14.4 CHILDREN

15 GLOBAL SKIN MICROBIOME MARKET, BY END USER

15.1 OVERVIEW

15.2 HOSPITALS

15.3 DERMATOLOGY HOSPITAL

15.4 SPECILITY HOSPITALS

15.5 SPA OR SALON

15.6 BEAUTY PARLERS

15.7 HOME HEALTHCARE

15.8 OTHERS

16 GLOBAL SKIN MICROBIOME MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 HOSPITAL PHARMACIES

16.3 RETAIL SALES

16.3.1 DRUG STORE

16.3.2 COMPANY OWNED BRANDED STORE

16.3.3 MULTIBRANDED STORE

16.3.4 OTHER

16.4 ONLINE SALES

16.4.1 COMPANY OWNED WEBSITE

16.4.2 E- COMMERCE WEBSITES

16.4.3 ONLINE PHARMACY

16.5 OTHER

17 GLOBAL SKIN MICROBIOME MARKET, COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: GLOBAL

17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

17.3 COMPANY SHARE ANALYSIS: EUROPE

17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

17.5 MERGERS & ACQUISITIONS

17.6 NEW PRODUCT DEVELOPMENT & APPROVALS

17.7 EXPANSIONS

17.8 REGULATORY CHANGES

17.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

17.1

18 GLOBAL SKIN MICROBIOME MARKET, BY COUNTRY

GLOBAL SKIN MICROBIOME MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

18.1 NORTH AMERICA

18.1.1 U.S.

18.1.2 CANADA

18.1.3 MEXICO

18.2 EUROPE

18.2.1 GERMANY

18.2.2 U.K.

18.2.3 ITALY

18.2.4 FRANCE

18.2.5 SPAIN

18.2.6 RUSSIA

18.2.7 SWITZERLAND

18.2.8 TURKEY

18.2.9 BELGIUM

18.2.10 NETHERLANDS

18.2.11 DENMARK

18.2.12 SWEDEN

18.2.13 POLAND

18.2.14 NORWAY

18.2.15 FINLAND

18.2.16 REST OF EUROPE

18.3 ASIA-PACIFIC

18.3.1 JAPAN

18.3.2 CHINA

18.3.3 SOUTH KOREA

18.3.4 INDIA

18.3.5 SINGAPORE

18.3.6 THAILAND

18.3.7 INDONESIA

18.3.8 MALAYSIA

18.3.9 PHILIPPINES

18.3.10 AUSTRALIA

18.3.11 NEW ZEALAND

18.3.12 VIETNAM

18.3.13 TAIWAN

18.3.14 REST OF ASIA-PACIFIC

18.4 SOUTH AMERICA

18.4.1 BRAZIL

18.4.2 ARGENTINA

18.4.3 REST OF SOUTH AMERICA

18.5 MIDDLE EAST AND AFRICA

18.5.1 SOUTH AFRICA

18.5.2 EGYPT

18.5.3 BAHRAIN

18.5.4 UNITED ARAB EMIRATES

18.5.5 KUWAIT

18.5.6 OMAN

18.5.7 QATAR

18.5.8 SAUDI ARABIA

18.5.9 REST OF MEA

18.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

19 GLOBAL SKIN MICROBIOME MARKET, SWOT AND DBMR ANALYSIS

20 GLOBAL SKIN MICROBIOME MARKET, COMPANY PROFILE

20.1 AURELIA LONDON

20.1.1 COMPANY OVERVIEW

20.1.2 REVENUE ANALYSIS

20.1.3 GEOGRAPHIC PRESENCE

20.1.4 PRODUCT PORTFOLIO

20.1.5 RECENT DEVELOPMENTS

20.2 GALLINÉE.

20.2.1 COMPANY OVERVIEW

20.2.2 REVENUE ANALYSIS

20.2.3 GEOGRAPHIC PRESENCE

20.2.4 PRODUCT PORTFOLIO

20.2.5 RECENT DEVELOPMENTS

20.3 DAKOTA BIOTECH

20.3.1 COMPANY OVERVIEW

20.3.2 REVENUE ANALYSIS

20.3.3 GEOGRAPHIC PRESENCE

20.3.4 PRODUCT PORTFOLIO

20.3.5 RECENT DEVELOPMENTS

20.4 MOTHER DIRT'S

20.4.1 COMPANY OVERVIEW

20.4.2 REVENUE ANALYSIS

20.4.3 GEOGRAPHIC PRESENCE

20.4.4 PRODUCT PORTFOLIO

20.4.5 RECENT DEVELOPMENTS

20.5 ESSE SKINCARE

20.5.1 COMPANY OVERVIEW

20.5.2 REVENUE ANALYSIS

20.5.3 GEOGRAPHIC PRESENCE

20.5.4 PRODUCT PORTFOLIO

20.5.5 RECENT DEVELOPMENTS

20.6 S-BIOMEDIC

20.6.1 COMPANY OVERVIEW

20.6.2 REVENUE ANALYSIS

20.6.3 GEOGRAPHIC PRESENCE

20.6.4 PRODUCT PORTFOLIO

20.6.5 RECENT DEVELOPMENTS

20.7 ELIZABETH ARDEN

20.7.1 COMPANY OVERVIEW

20.7.2 REVENUE ANALYSIS

20.7.3 GEOGRAPHIC PRESENCE

20.7.4 PRODUCT PORTFOLIO

20.7.5 RECENT DEVELOPMENTS

20.8 YUN PEROBIOTHERAPY

20.8.1 COMPANY OVERVIEW

20.8.2 REVENUE ANALYSIS

20.8.3 GEOGRAPHIC PRESENCE

20.8.4 PRODUCT PORTFOLIO

20.8.5 RECENT DEVELOPMENTS

20.9 TULA LIFE, INC

20.9.1 COMPANY OVERVIEW

20.9.2 REVENUE ANALYSIS

20.9.3 GEOGRAPHIC PRESENCE

20.9.4 PRODUCT PORTFOLIO

20.9.5 RECENT DEVELOPMENTS

20.1 THE BEAUTY CHEF.

20.10.1 COMPANY OVERVIEW

20.10.2 REVENUE ANALYSIS

20.10.3 GEOGRAPHIC PRESENCE

20.10.4 PRODUCT PORTFOLIO

20.10.5 RECENT DEVELOPMENTS

20.11 L’OREAL PARIS

20.11.1 COMPANY OVERVIEW

20.11.2 REVENUE ANALYSIS

20.11.3 GEOGRAPHIC PRESENCE

20.11.4 PRODUCT PORTFOLIO

20.11.5 RECENT DEVELOPMENTS

20.12 CLINIQUE LABORATORIES, LLC.

20.12.1 COMPANY OVERVIEW

20.12.2 REVENUE ANALYSIS

20.12.3 GEOGRAPHIC PRESENCE

20.12.4 PRODUCT PORTFOLIO

20.12.5 RECENT DEVELOPMENTS

20.13 LA ROCHE-POSAY

20.13.1 COMPANY OVERVIEW

20.13.2 REVENUE ANALYSIS

20.13.3 GEOGRAPHIC PRESENCE

20.13.4 PRODUCT PORTFOLIO

20.13.5 RECENT DEVELOPMENTS

20.14 BEBE & BELLA, LLC.

20.14.1 COMPANY OVERVIEW

20.14.2 REVENUE ANALYSIS

20.14.3 GEOGRAPHIC PRESENCE

20.14.4 PRODUCT PORTFOLIO

20.14.5 RECENT DEVELOPMENTS

20.15 AMOREPACIFIC,

20.15.1 COMPANY OVERVIEW

20.15.2 REVENUE ANALYSIS

20.15.3 GEOGRAPHIC PRESENCE

20.15.4 PRODUCT PORTFOLIO

20.15.5 RECENT DEVELOPMENTS

20.16 BELANO MEDICAL AG

20.16.1 COMPANY OVERVIEW

20.16.2 REVENUE ANALYSIS

20.16.3 GEOGRAPHIC PRESENCE

20.16.4 PRODUCT PORTFOLIO

20.16.5 RECENT DEVELOPMENTS

20.17 GLOWBIOTICS LLC

20.17.1 COMPANY OVERVIEW

20.17.2 REVENUE ANALYSIS

20.17.3 GEOGRAPHIC PRESENCE

20.17.4 PRODUCT PORTFOLIO

20.17.5 RECENT DEVELOPMENTS

20.18 AOBIOME

20.18.1 COMPANY OVERVIEW

20.18.2 REVENUE ANALYSIS

20.18.3 GEOGRAPHIC PRESENCE

20.18.4 PRODUCT PORTFOLIO

20.18.5 RECENT DEVELOPMENTS

20.19 LAFLORE

20.19.1 COMPANY OVERVIEW

20.19.2 REVENUE ANALYSIS

20.19.3 GEOGRAPHIC PRESENCE

20.19.4 PRODUCT PORTFOLIO

20.19.5 RECENT DEVELOPMENTS

20.2 ESTÉE LAUDER INC

20.20.1 COMPANY OVERVIEW

20.20.2 REVENUE ANALYSIS

20.20.3 GEOGRAPHIC PRESENCE

20.20.4 PRODUCT PORTFOLIO

20.20.5 RECENT DEVELOPMENTS

20.21 ALGENIST

20.21.1 COMPANY OVERVIEW

20.21.2 REVENUE ANALYSIS

20.21.3 GEOGRAPHIC PRESENCE

20.21.4 PRODUCT PORTFOLIO

20.21.5 RECENT DEVELOPMENTS

20.22 BEBE & BELLA

20.22.1 COMPANY OVERVIEW

20.22.2 REVENUE ANALYSIS

20.22.3 GEOGRAPHIC PRESENCE

20.22.4 PRODUCT PORTFOLIO

20.22.5 RECENT DEVELOPMENTS

20.23 DSM

20.23.1 COMPANY OVERVIEW

20.23.2 REVENUE ANALYSIS

20.23.3 GEOGRAPHIC PRESENCE

20.23.4 PRODUCT PORTFOLIO

20.23.5 RECENT DEVELOPMENTS

20.24 EMINENCE ORGANIC SKIN CARE

20.24.1 COMPANY OVERVIEW

20.24.2 REVENUE ANALYSIS

20.24.3 GEOGRAPHIC PRESENCE

20.24.4 PRODUCT PORTFOLIO

20.24.5 RECENT DEVELOPMENTS

20.25 BIOPHILE

20.25.1 COMPANY OVERVIEW

20.25.2 REVENUE ANALYSIS

20.25.3 GEOGRAPHIC PRESENCE

20.25.4 PRODUCT PORTFOLIO

20.25.5 RECENT DEVELOPMENTS

20.26 PIERRE FABRE GROUP

20.26.1 COMPANY OVERVIEW

20.26.2 REVENUE ANALYSIS

20.26.3 GEOGRAPHIC PRESENCE

20.26.4 PRODUCT PORTFOLIO

20.26.5 RECENT DEVELOPMENTS

20.27 SIOLTA THERAPEUTICS

20.27.1 COMPANY OVERVIEW

20.27.2 REVENUE ANALYSIS

20.27.3 GEOGRAPHIC PRESENCE

20.27.4 PRODUCT PORTFOLIO

20.27.5 RECENT DEVELOPMENTS

20.28 IORA INDIA

20.28.1 COMPANY OVERVIEW

20.28.2 REVENUE ANALYSIS

20.28.3 GEOGRAPHIC PRESENCE

20.28.4 PRODUCT PORTFOLIO

20.28.5 RECENT DEVELOPMENTS

20.29 PROTA SKINCARE

20.29.1 COMPANY OVERVIEW

20.29.2 REVENUE ANALYSIS

20.29.3 GEOGRAPHIC PRESENCE

20.29.4 PRODUCT PORTFOLIO

20.29.5 RECENT DEVELOPMENTS

20.3 SABINSA.

20.30.1 COMPANY OVERVIEW

20.30.2 REVENUE ANALYSIS

20.30.3 GEOGRAPHIC PRESENCE

20.30.4 PRODUCT PORTFOLIO

20.30.5 RECENT DEVELOPMENTS

NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

21 RELATED REPORTS

22 CONCLUSION

23 QUESTIONNAIRE

24 ABOUT DATA BRIDGE MARKET RESEARCH

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The global skin microbiome market size was valued at USD 1.03 billion in 2024.
The global skin microbiome market is to grow at a CAGR of 13.68 % during the forecast period of 2025 to 2032.
The skin microbiome market is segmented into three notable segments based on type, skin type, and disease. On the basis of type, the market is segmented into resident microorganisms, and transient bacteria. On the basis of skin type, the market is segmented into dry, moist, and oily. On the basis of disease, the market is segmented into acne vulgaris, atopic dermatitis, psoriasis and vulgaris, rosacea.
Companies like S-BIOMEDIC (Belgium), Elizabeth Arden (Switzerland), YUN (Belgium), TULA Life, Inc. (U.S.) and The Beauty Chef (Australia) are the major companies in the skin microbiome market.
In February 2025, Phyla, a skincare brand backed by Ryan Reynolds, launched a breakthrough acne treatment using bacteriophages to target Cutibacterium acnes, the bacteria primarily responsible for acne. The Acne Phage Serum (USD 70) offers a natural and highly targeted method, with early users reporting notable improvements. In December 2024, French brand Gallinée released a microbiome-friendly Anti-Ageing Face Recovery Mask, formulated with prebiotics and probiotics to support skin barrier restoration, hydration, and radiance
The countries covered in the skin microbiome market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.
The rising focus on personalized and probiotic skincare solutions, is emerging as a pivotal trend driving the global Skin Microbiome market.
The resident microorganisms, segment is expected to dominate the global skin microbiome market holding a major market share in 2025, due to crucial role in maintaining long-term skin health.
Asia-Pacific is the fastest growing region in the global skin microbiome market due to rising awareness of skin health, increasing disposable income, and growing demand for clean, natural, and customized skincare
The major factors driving the growth of the skin microbiome market are growing need due to Increasing skin disorders and demand for natural, microbiome-friendly solutions and advancements in microbiome research, and rising demand for personalized skincare solutions
The primary challenges include high development costs and regulatory hurdles limiting market expansion and limited scientific understanding of the complex skin microbiota
U.S. is expected to dominate the global skin microbiome market, particularly in the North America region. This dominance is attributed to its growing demand for personalized skincare solutions, increased prevalence of skin conditions such as acne and eczema, and an established culture of wellness-focused beauty consumption
North America is expected to dominate the global skin microbiome market due to high consumer awareness, widespread adoption of probiotic and science-backed skincare, and the strong presence of major skincare and biotechnology companies
India is expected to witness the highest CAGR in the skin microbiome market. This growth is driven by its large, youthful populations and expanding interest in skin wellness and preventative skincare solutions
Testimonial